We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Roche and Sysmex Expand 25-Year Partnership to Foster More Sustainable Diagnostic Solutions

By LabMedica International staff writers
Posted on 04 Aug 2023

Roche (Basel, Switzerland) and Sysmex Corporation (Kobe, Japan) have expanded their Global Business Partnership Agreement. More...

The renewed agreement reinforces the commitment of both companies to their long-established collaboration. Under the revised terms, Roche, which has been collaborating with Sysmex for 25 years, will continue to offer Sysmex's hematology products, complementing its comprehensive laboratory solutions portfolio. The Global Business Partnership Agreement between Roche and Sysmex promises to assist patients requiring diagnostic solutions and aims to enhance the efficiency and effectiveness of lab testing by offering integrated in-vitro diagnostics (IVD) technologies through a single provider.

The commercial and R&D collaboration between Roche and Sysmex was initiated in 1998, and the companies have since consistently strengthened their partnership. In 2020, both companies signed the Global Business Partnership Agreement to broaden their partnership further and enhance the customer experience. As of 2023, with updated terms and an expanded scope, both companies have reaffirmed their long-standing partnership and commitment to fostering a more sustainable future for society. The revised non-exclusive agreement ushers in a new dimension of cooperation, incorporating an additional eco-social agreement to jointly investigate more sustainable diagnostic solutions. By extending their long-standing collaboration beyond the current portfolio, both companies have demonstrated their commitment to seeking more sustainable solutions.

“We are delighted to expand our 25-year partnership with Sysmex in the area of hematology and in exploring more sustainable diagnostics solutions,” said Matt Sause, CEO of Roche Diagnostics. “Roche and Sysmex both have a long-standing history of delivering reliable and innovative solutions for patients and I am very happy to see this collaboration grow.”

“We are pleased to announce the renewal of our partnership with Roche, reaffirming our commitment to long-term collaboration,” added Kaoru Asano, President of Sysmex Corporation. “Developing our partnerships in the field of diagnostics even further and addressing enduring eco-social challenges represents a significant milestone in advancing our alliance to the next level. Together, we firmly believe in making even greater contributions to our customers in laboratories and creating a sustainable society."

Related Links:
Roche
Sysmex Corporation


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: USU chemists Kadin Crosby, Bamidele Filani, and Ryan Jackson have reported newly discovered functions of CRISPR-Cas12a3 (Photo courtesy of USU/M. Muffoletto)

CRISPR Discovery Paves Way for Single Diagnostic Test for COVID, Flu and RSV

Immune systems across all forms of life defend against viruses by blocking their ability to replicate. Many CRISPR-based defenses achieve this by cutting viral DNA, but these approaches can damage host... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.